Jennifer Corbett Dooren

Denny Hatch is the author of six books on marketing and four novels, and is a direct marketing writer, designer and consultant. His latest book is “Write Everything Right!” Visit him at

Check out the July 15th story in the IN THE NEWS section at right.

The diabetes drug Avandia has been allowed to remain on the market even though a large percentage of the medical community believes it raises the risk of heart attacks and should be banned.

The next day, Avandia’s maker, GlaxoSmithKline, announced it had set aside $2.4 billion to settle lawsuits from consumers that believe they suffered harm from the drug.

Outrageous? Nah.

Business as usual in the gazillion-dollar world of Pharmaceuticals.

More Blogs